{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T21:44:16Z","timestamp":1743803056440},"publisher-location":"Boston, MA","reference-count":16,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461374442"},{"type":"electronic","value":"9781461553571"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998]]},"DOI":"10.1007\/978-1-4615-5357-1_82","type":"book-chapter","created":{"date-parts":[[2011,8,8]],"date-time":"2011-08-08T01:46:01Z","timestamp":1312767961000},"page":"531-537","source":"Crossref","is-referenced-by-count":7,"title":["Gene Therapy with Cytokine-Transfected Xenogeneic Cells in Metastatic Tumors"],"prefix":"10.1007","author":[{"given":"Christoph F.","family":"Rochlitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Jantscheff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bongartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-Y.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Quiquerez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mehtali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Courtney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tartour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Dorval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. H.","family":"Fridman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"82_CR1","first-page":"281","volume":"57","author":"C Roth","year":"1994","unstructured":"Roth C, Rochlitz CF, Kourilsky P, 1994; Immune response against tumors. Adv. Immunol. 57, 281\u2013351.","journal-title":"Immunol"},{"key":"82_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/jnci\/89.1.21","volume":"89","author":"JA Roth","year":"1997","unstructured":"Roth JA, Cristiano RJ, 1997; Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst. 89, 21\u201339.","journal-title":"J. Natl. Cancer Inst"},{"key":"82_CR3","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/intimm\/4.12.1429","volume":"4","author":"C Roth","year":"1992","unstructured":"Roth C, Mir LM, Cressent M, Quintin-Colonna F, Ley V, Fradelizi D, et al., 1992; Inhibition of tumor growth by histoincompatible cells expressing interleukin-2. Int. Immunol. 4, 1429\u20131436.","journal-title":"Int. Immunol"},{"key":"82_CR4","first-page":"1104","volume":"3","author":"F Quintin-Colonna","year":"1996","unstructured":"Quintin-Colonna F, Devauchelle P, Fradelizi D, Mourot B, Faure T, Kourilsky P, et al., 1996; Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2. Gene Ther. 3, 1104\u20131112.","journal-title":"Gene Ther"},{"key":"82_CR5","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1073\/pnas.90.9.4319","volume":"90","author":"C Pannetier","year":"1993","unstructured":"Pannetier C, Cochet M, Darche S, Casrouge A, Z\u00f6ller M, Kourilsky P., 1993; The sizes of the CD3 hyper-variable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. U S A 90, 4319\u20134323.","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"82_CR6","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood.V80.9.2419.2419","volume":"80","author":"PY Dietrich","year":"1992","unstructured":"Dietrich PY, Caignard A, Diu A, Genev\u00e9e C, Pico JL, Henry-Amar M, et al., 1992; Analysis of T cell receptor variability in transplanted patients with human cutaneous acute graft versus host disease. Blood, 80, 2419\u20132424.","journal-title":"Blood"},{"key":"82_CR7","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1182\/blood.V84.8.2815.2815","volume":"84","author":"PY Dietrich","year":"1994","unstructured":"Dietrich PY, Caignard A, Lim A, Chung V, Pico JL, Pannetier C, et al., 1994; In vivo T-cell clonal amplification in human acute graft versus host disease. Blood, 84, 2815\u20132820.","journal-title":"Blood"},{"key":"82_CR8","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/clinchem\/41.8.1087","volume":"41","author":"B van-Hille","year":"1995","unstructured":"van-Hille B, Lohri A, Reuter J, Herrmann R., 1995; Nonradioactive quantification of mdrl mRNA by polymerase chain reaction amplification coupled with HPLC. Clin. Chem., 41, 1087\u20131093.","journal-title":"Clin. Chem."},{"key":"82_CR9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/ijc.2910570428","volume":"57","author":"U L\u00fcscher","year":"1994","unstructured":"L\u00fcscher U, Filgueira L, Juretic A, Zuber M, L\u00fcscher NJ, Heberer M, et al., 1994; The pattern of cytokine expression in freshly excised human metastatic melanoma suggests a state of reversible anergy tumor-infiltrating lymphocytes. Int. J. Cancer, 57, 612\u2013619.","journal-title":"Int. J. Cancer"},{"key":"82_CR10","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1001\/jama.1994.03510360033032","volume":"271","author":"SA Rosenberg","year":"1994","unstructured":"Rosenberg SA, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, et al., 1994; Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus in-terleukin 2. JAMA, 271, 907\u2013913.","journal-title":"JAMA"},{"key":"82_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0092-8674(90)90591-2","volume":"60","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons JW, et al., 1990; Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell, 60, 397\u2013403.","journal-title":"Cell"},{"key":"82_CR12","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1084\/jem.172.4.1217","volume":"172","author":"B Gansbacher","year":"1990","unstructured":"Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R, Gilboa E., 1990; Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med., 172, 1217\u20131224.","journal-title":"J. Exp. Med."},{"key":"82_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0165-2478(90)90074-Z","volume":"23","author":"J Bubenik","year":"1990","unstructured":"Bubenik J, Simova J, Jandlova T., 1990; Immunotherapy of cancer using local administration of lymphoid cells expressing IL-2 cDNA and constitutively producing IL-2. Immunol. Let, 23, 287\u2013292.","journal-title":"Immunol. Let"},{"key":"82_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1084\/jem.170.3.797","volume":"170","author":"T W\u00f6lfel","year":"1989","unstructured":"W\u00f6lfel T, Klehmann E, M\u00fcller C, Schutt K-H, Meyer zum B\u00fcschenfelde K-H, Knuth A., 1989; Lysis of human melanoma cells by autologous cytolytic T cell clones. J. Exp. Med., 170, 797\u2013810.","journal-title":"J. Exp. Med."},{"key":"82_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0167-5699(97)84664-6","volume":"18","author":"SA Rosenberg","year":"1997","unstructured":"Rosenberg SA., 1997; Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today, 18, 175\u2013182.","journal-title":"Immunol. Today"},{"key":"82_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00002371-199601000-00009","volume":"19","author":"SA Rosenberg","year":"1996","unstructured":"Rosenberg SA, White DE., 1996; Vitiligo in patients with melanoma: Normal tissue antigens can be targets for cancer immunotherapy. J. Immunother., 19, 81\u201384.","journal-title":"J. Immunother."}],"container-title":["Advances in Experimental Medicine and Biology","Gene Therapy of Cancer"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-5357-1_82.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T06:43:42Z","timestamp":1605681822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-5357-1_82"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998]]},"ISBN":["9781461374442","9781461553571"],"references-count":16,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-5357-1_82","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[1998]]}}}